Does insurance cover hormone therapy? Medicare, Medicaid and private plans

In the US, menopausal hormone therapy is covered the way any other prescription is covered: through your plan’s drug benefit, according to its formulary, with the copay or coinsurance for the tier your product lands on. There is no special menopause exclusion in Medicare, Medicaid or ACA plans. The variation you hear about comes from formularies, prior authorization and whether your prescription matches a product your plan prefers.

How prescription coverage works, in plain terms

Every drug plan keeps a formulary, a list of covered medications sorted into tiers. Lower tiers (usually generics) cost you less; higher tiers (brand names, specialty drugs) cost more. Plans use three main tools to steer you toward preferred products:

• Prior authorization: the plan wants a reason from your clinician before it pays.
• Step therapy: you must try a preferred drug first.
• Quantity limits: a maximum amount per fill.

Hormone therapy comes in many forms: estradiol pills, patches, gels and sprays; conjugated estrogens; progesterone capsules and other progestogens; vaginal estrogen creams, tablets, inserts and rings; combination products. A plan may cover some generically and others not at all. The single most useful move is to ask the pharmacist, before you leave the counter, which versions of your drug are on the formulary and what each would cost.

Plan type	Who runs it	Where to check coverage
Employer or private plan	Insurer chosen by your employer or you	Plan formulary (member website) or member services phone line
ACA Marketplace plan	Private insurer, regulated under the ACA	Plan’s drug list, linked from HealthCare.gov or your state exchange when you compare plans
Medicare Part D or Medicare Advantage with drug coverage	Private plans approved by Medicare	Medicare Plan Finder on Medicare.gov, or the plan’s formulary
Medicaid	Your state, often through a managed care plan	State preferred drug list; your managed care plan’s formulary

Medicare

Medicare drug coverage (Part D) is optional, offered by private insurers approved by Medicare, either as a stand-alone plan alongside Original Medicare or built into a Medicare Advantage plan. Medicare.gov states that all plans must cover a wide range of prescription drugs that people with Medicare take, including most drugs in certain protected classes such as cancer, HIV and depression treatments. Hormone therapy is not a protected class, so whether a given product is covered depends on the individual plan’s formulary.

Costs in 2026, according to Medicare.gov:

• Deductible: varies by plan, but no Part D plan may charge more than $615 in 2026 (rising to $700 in 2027). Some plans have no deductible.
• Initial coverage: after the deductible, you generally pay 25 percent coinsurance for covered generic and brand drugs.
• Out-of-pocket cap: once your spending on covered Part D drugs reaches $2,100 in 2026 (rising to $2,400 in 2027), you pay nothing more for covered drugs for the rest of the year. CMS describes the $2,100 figure as the 2025 cap of $2,000 adjusted for inflation.
• Medicare Prescription Payment Plan: plans are required to offer the option of spreading your out-of-pocket drug costs across the year in monthly payments instead of paying at the pharmacy.

Two practical points. First, during Medicare open enrollment you can enter your actual prescriptions into the Plan Finder and see what each plan would charge for the year. If you take hormone therapy, do this; the differences between plans for the same drug can be large. Second, if your plan does not cover the product your clinician prescribed, you can ask for a formulary exception, which requires your clinician to explain why the covered alternatives are not appropriate.

Menopause visits themselves, in person or by telehealth, fall under Part B, with the Part B deductible and 20 percent coinsurance; see telehealth for menopause care.

Medicaid

Medicaid is a joint federal and state program, and each state decides the details of its drug benefit. In practice this means your state maintains a preferred drug list, decides which hormone therapy products need prior authorization, and sets copays, which are low or zero for most enrollees. If you are in a Medicaid managed care plan, that plan may have its own formulary.

The reliable way to check is to look up your state’s preferred drug list, ask your pharmacist to run the prescription, or call the member services line on your Medicaid card. If a product is denied, your clinician can request prior authorization or switch to a preferred generic.

ACA Marketplace and employer plans

Under the ACA, all Marketplace plans must cover ten categories of essential health benefits, and prescription drugs are one of them. HealthCare.gov notes that the specific services covered within each category can vary by state, and each plan builds its own formulary. So a plan must have a drug benefit, but it need not cover every hormone therapy product.

Employer plans are not required to cover all essential health benefits in the same way, but nearly all include a drug benefit. Large employers often use a pharmacy benefit manager whose formulary is separate from the medical plan. The member website usually has a drug lookup tool; search for the generic name (for example, estradiol) rather than a brand.

Things that commonly trip people up:

• Brand-only prescriptions. If the clinician writes “dispense as written” for a brand, the plan may charge the highest tier or deny it. Ask whether a generic is acceptable.
• Vaginal estrogen. Some plans place low-dose vaginal products on higher tiers than systemic generics. Check the specific product.
• Compounded hormones and pellets. Compounded preparations are generally not on formularies and are paid out of pocket. ACOG recommends FDA-approved products over compounded ones in any case.
• Deductible plans. On a high-deductible plan, you pay the plan’s negotiated price in full until the deductible is met. Ask the pharmacist for the cash price too; sometimes it is lower than the insurance price for a generic.

HSA and FSA

Money in a health savings account or flexible spending account can be used tax-free for qualified medical expenses. IRS Publication 502 states that amounts paid for prescribed medicines and drugs count, as do payments to physicians and other clinicians, and insurance copays. Publication 969 defines qualified medical expenses for HSAs by reference to the same definition of medical care and notes that menstrual care products are treated as medical care.

So prescription hormone therapy, a telehealth visit fee at a cash-pay practice, and your copays are all eligible. Lubricants, moisturizers and supplements bought over the counter follow the separate over-the-counter rules; check Publication 969 or your plan administrator before relying on reimbursement.

Keep itemized receipts and, for a cash-pay clinician, ask for a receipt that includes the clinician’s name, NPI and the service.

What to do when coverage is denied

1. Ask the pharmacist why. “Not on formulary,” “prior authorization required” and “quantity limit” each have a different fix.
2. Switch products. Most of the time a covered generic will do the same job. Your clinician can send a new prescription the same day.
3. Request prior authorization or an exception. The clinician’s office handles the paperwork; your job is to tell them promptly.
4. Appeal. Every plan type, including Medicare and Medicaid, has an appeals process with deadlines. The denial letter explains it.
5. Compare cash prices. For generics, the cash price at another pharmacy or a mail-order pharmacy is sometimes lower than your copay.

If you are still choosing a clinician, ask the practice whether it checks coverage before prescribing. Many menopause-focused practices do, which avoids a surprise at the pharmacy. See how to find a menopause specialist for what else to ask.